Elevance Health Inc.
Elevance Health Announces First Quarter 2025 Financial Results and Outlook
Summary
Elevance Health, Inc. announced that it will release its first quarter 2025 financial results on April 22, 2025. The company expects to report GAAP shareholders' net income of $9.61 per diluted share, with adjusted shareholders' net income at $11.97 per diluted share. The medical cost trends were in line with expectations, particularly in the Medicare Advantage business. The company also intends to reaffirm its full-year 2025 adjusted net income guidance of $34.15 to $34.85 per diluted share.
Profitelligence Alerts
Get alerts for ELV
Be first to know when Elevance Health Inc. files with the SEC.
Filing Categories
Advertisement
About Elevance Health Inc.
Elevance Health Inc., formerly known as Anthem, is a prominent health insurance company in the United States. Its primary function is to provide a wide range of health insurance products and related services to a diverse customer base, including individuals, families, and businesses. Elevance Health focuses on enhancing health and well-being by offering managed care plans tailored to the varying needs of its clients. With a robust portfolio, Elevance Health caters to multiple sectors within the healthcare industry, influencing stakeholders such as healthcare providers, pharmaceutical companies, and medical technology firms. The company plays a critical role in the healthcare market by negotiating coverage terms, managing costs, and ensuring policyholders have access to necessary medical services. As one of the largest health insurers in the nation, Elevance Health holds significant market influence, contributing to shaping healthcare policies and practices through its vast network and strategic partnerships. By leveraging technology and data analytics, the company aims to improve patient outcomes, streamline insurance processes, and foster advancements in personalized healthcare solutions.
Official SEC Documents
Advertisement